Significance of Fas expression alteration during tumor progression of renal cell carcinoma
β Scribed by TAKEHIRO SEJIMA; IKUO MIYAGAWA
- Book ID
- 108976975
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 360 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0919-8172
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
CD95/APO-1 ligand (FasL) is implicated in the maintenance of immune privileged sites by inducing apoptosis of activated infiltrating T lymphocytes. Therefore, progressive tumors might express high levels of FasL and develop as immune privileged sites. In this study, we investigated the expression of
## Abstract Accumulating evidences indicate that cyclooxygenase (COX)β2 plays an important role in tumorigenesis in many human cancers. Yet the relationship between COXβ2 and human renal cell carcinoma (RCC) remains unclear. The aim of our study was to evaluate COXβ2 expression in human RCC cell li